Stryker’s newly FDA-cleared Incompass® Total Ankle System marks a significant advancement in orthopedic innovation, combining the strengths of the company’s previous Inbone® and Infinity® systems into one cohesive platform. Developed using over 85,000 CT scans and 100,000 clinical cases, the system incorporates Adaptis® Boney Ingrowth Technology, offering enhanced fixation and anatomical alignment. Built on Stryker’s SOMA (Stryker Orthopaedic Modeling & Analytics) platform, Incompass leverages detailed data insights and surgical planning capabilities to deliver a new level of precision and adaptability in total ankle replacement.

The Incompass system is designed to address long-standing challenges in total ankle arthroplasty, including intraoperative flexibility and workflow optimization. With updated implant holders, a redesigned alignment system, and streamlined instrumentation, surgeons gain improved control across multiple planes and reduced procedural complexity. These features enable faster setup times, customizable implant selection, and a more patient-specific approach—making it ideal for treating severe degenerative, post-traumatic, or rheumatoid arthritis of the ankle joint.

In conclusion, the Incompass Total Ankle System represents a critical step forward in modernizing ankle replacement procedures. By fusing decades of clinical expertise with the latest data-driven technologies, Stryker is redefining surgical standards in foot and ankle care. The system’s approval further solidifies Stryker’s leadership in orthopaedic innovation and supports improved surgical outcomes, patient satisfaction, and long-term joint function.

MedTech Spectrum's Summary

Comprehensive Innovation: Integrates the best features of Stryker’s Inbone® and Infinity® systems, enhanced with Adaptis® Boney Ingrowth Technology and powered by SOMA analytics for data-driven precision in total ankle replacement.

Enhanced Surgical Efficiency: Features redesigned alignment tools, improved instrumentation, and intraoperative adaptability—streamlining procedures, reducing setup time, and supporting patient-specific care.

Elevating Standards in Foot & Ankle Care: FDA clearance positions Incompass as a next-generation solution for severe ankle arthritis, reinforcing Stryker’s leadership in orthopaedic innovation and long-term joint restoration.